News

Panobacumab, a fully human IgM monoclonal antibody, is an immunotherapy for these life-threatening infections, and this clinical trial reveals its potential as a more effective treatment than standard

The data demonstrates that SYN-115 improves measures of motor and non-motor function in patients either alone or in combination with levodopa. The results clearly illustrate the value of

Idenix Pharmaceuticals said that the positive pharmacokinetic profile defined in preclinical studies was confirmed by interim Phase I clinical data in healthy volunteers. Additional data presented demonstrated that

Locteron, a controlled-release interferon alpha 2b, is designed to improve patient care by providing a more convenient once-every-two week dosing schedule and by reducing the flu-like symptoms associated

As per the agreement, Genocea Biosciences will receive $2.7m from the US Army Medical Research and Materiel Command (USAMRMC) for rapid T-cell antigen discovery using human T-cell screens

The IMAGE study is a multicenter, randomized clinical trial of 602 heart transplant patients comparing XDx’s AlloMap Molecular Expression Testing, a noninvasive rejection surveillance method utilizing gene expression

Cefprozil (Cefzil) is a cephalosporin antibiotic. It treats many kinds of infections, including those of the respiratory tract, skin, ears. Cefprozil is the generic equivalent of Canadian reference

Global Vision said that BraillePoint uses precision electronic measurement technology to measure dots in their original form in contrast to using a two-dimensional image, and claims that this

Pharmalucence is expected to implement Pilgrim Software’s solutions for document management, change control, training management, and events (CAPA) management at its Massachusetts based operations. With the pilgrim platform